Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,041 | 71,136 | -173,749 | -115,521 | -56,763 |
| Depreciation Amortization | 3,269 | 8,586 | 5,336 | 3,229 | 1,502 |
| Accounts payable and accrued liabilities | 623 | -1,623 | 147 | -744 | -292 |
| Other Working Capital | -3,803 | 288,401 | 35,780 | -7,809 | -9,642 |
| Other Operating Activity | 19,712 | 49,652 | 34,723 | 22,996 | 10,703 |
| Operating Cash Flow | $-50,240 | $416,152 | $-97,763 | $-97,849 | $-54,492 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,800 | -3,095 | -1,900 | -1,194 | -879 |
| Purchase Of Investment | -463,105 | -1,285,468 | -687,523 | -323,607 | -153,155 |
| Sale Of Investment | 440,500 | 665,357 | 433,557 | 281,057 | 140,701 |
| Investing Cash Flow | $-25,405 | $-623,206 | $-255,866 | $-43,744 | $-13,333 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,822 | 440,801 | 431,279 | 5,380 | 195,913 |
| Other Financing Activity | 0 | 193,948 | 193,948 | 193,948 | 0 |
| Financing Cash Flow | $3,822 | $634,749 | $625,227 | $199,328 | $195,913 |
| Beginning Cash Position | 508,644 | 80,949 | 80,949 | 80,949 | 80,949 |
| End Cash Position | 436,821 | 508,644 | 352,547 | 138,684 | 209,037 |
| Net Cash Flow | $-71,823 | $427,695 | $271,598 | $57,735 | $128,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,240 | 416,152 | -97,763 | -97,849 | -54,492 |
| Capital Expenditure | -2,800 | -3,095 | -1,900 | -1,194 | -879 |
| Free Cash Flow | -53,040 | 413,057 | -99,663 | -99,043 | -55,371 |